As a cannabis business accelerator, Liberty Leaf makes carefully considered investments in growth-oriented, legal cannabis ventures. Here are our leading investments to date:
North Road Ventures was acquired by Liberty Leaf in October, 2016. It is an emerging distributor of cultivated and manufactured cannabis products to licenced legal retailers. The company is expanding into the recreational market. North Road currently occupies a leased commercial space in Metro Vancouver. North Road has an application pending with Health Canada for a ACMPR license.
Distribution drives Liberty Leaf’s plans in $8 billion Canadian cannabis market
Liberty Leaf's North Road cannabis distribution model brings the same end-to-end discipline and supply chain mastery used by established brands in the food and beer/wine/spirit industries.
Liberty Leaf has Acquired the majority interest in Just Kush – a late-stage ACMPR Applicant and a company in control of a current MMAR-licensed facility. The acquisition puts two ACMPR licences in play, strengthening Liberty Leaf’s strategic position as a forward-thinking, vertically-integrated cannabis company
ESEV Genetics is developing the world’s first genomic platform for high value crop and advancing medicine and foods plant-derived solutions, to improve people’s life.
Blox Labs Inc. (CSE: BLOX) (FSE: BR1B) is a boutique technology development company that is focused on creating best-in-class software solutions that are driven by emerging trends in Blockchain, Smart Contracts and Decentralized Application Technologies. BLOX is actively targeting strategic acquisitions of high growth companies in the technology sector and is open to partnerships.